AUSTIN PRINCE: Open Payments
NPI 1962074682 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 20 payments from 6 companies in 2025. Trend: 2023 $621 · 2024 $1,090 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $238 |
| E.R. Squibb & Sons, L.L.C. | 9 | $213 |
| ABBVIE INC. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: INGREZZA, COBENFY, VRAYLAR, INVEGA SUSTENNA, LYBALVI, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
